Evidence map›Paper›PMID 31311324›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2019

NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress.

Alon Simchovitz, Mor Hanan, Naomi Niederhoffer, Nimrod Madrer, Nadav Yayon, Estelle R Bennett, David S Greenberg, Sebastian Kadener, Hermona Soreq

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 1 synthesis or guideline pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. ThebioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Review
  5. Epigenetic mechanisms of Parkinson's disease and potential epigenetic-based therapeutics.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Alon SimchovitzDepartment of Biological Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.
Mor HananDepartment of Biological Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.
Naomi NiederhofferDepartment of Biological Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.
Nimrod MadrerDepartment of Biological Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.
Nadav YayonDepartment of Biological Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.
Estelle R BennettDepartment of Biological Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.
David S GreenbergDepartment of Biological Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.
Sebastian KadenerBiology Department, Brandeis University, Waltham, Massachusetts, USA.
Hermona SoreqDepartment of Biological Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.
Hebrew University of Jerusalem · ILBrandeis University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent reports attribute numerous regulatory functions to the nuclear paraspeckle-forming long noncoding RNA, nuclear enriched assembly transcript 1 (NEAT1), but the implications of its involvement in Parkinson's disease (PD) remain controversial. To address this issue, we assessed NEAT1 expression levels and cell type patterns in the substantia nigra (SN) from 53 donors with and without PD, as well as in interference tissue culture tests followed by multiple in-house and web-available models of PD. PCR quantification identified elevated levels of NEAT1 expression in the PD SN compared with control brains, an elevation that was reproducible across a multitude of disease models.

Indexed as

BrainCell LineHEK293 CellsHumansNeuronsNeuroprotectionOxidative StressParkinson DiseaseRNA InterferenceRNA, Long NoncodingSubstantia NigraNEAT1 long non-coding RNA, humanRNA, Long NoncodinglncRNAneurodegenerationparaspeckles

Identifiers

PMID31311324
PMCPMC6766647
OpenAlexW2957860555

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.